Brief: Integra Lifesciences Reports Q4 Revenue Of $398 Million
22/02/2023 11:04
Feb 22 (Reuters) - Integra Lifesciences Q4 revenue USD 398 million. * Q4 EPS USD 0.63 * Q4 adjusted EPS USD 0.94 * Q4 adjusted EBITDA USD 109.7 million * Q4 adjusted net income USD 78.8 million * Outlook FY revenue USD 1,602-1,620 million
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes